title: Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy.
authors.affiliation: Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK.
authors.forename: P
authors.initials: P
authors.lastname: von Dadelszen
authors.forename: M D
authors.initials: MD
authors.lastname: Gillmer
authors.forename: M D
authors.initials: MD
authors.lastname: Gray
authors.forename: H P
authors.initials: HP
authors.lastname: McEwan
authors.forename: R J
authors.initials: RJ
authors.lastname: Pyper
authors.forename: T P
authors.initials: TP
authors.lastname: Rollason
authors.forename: A
authors.initials: A
authors.lastname: Wright
mesh_terms: D000230:Adenocarcinoma / Q000139:chemically induced* / Q000473:pathology; D000368:Aged; D004714:Endometrial Hyperplasia / Q000139:chemically induced* / Q000473:pathology; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009652:Norpregnenes / Q000009:adverse effects*
chemical_list: D009652:Norpregnenes; C027385:tibolone